Jump to ContentJump to Main Navigation
Show Summary Details
Weitere Optionen …


Emerging Science

Open Access
Alle Formate und Preise
Weitere Optionen …

Research Article. Perfluoroalkylated substances in human urine: results of a biomonitoring pilot study

Christina Hartmann / Wolfgang Raffesberg / Sigrid Scharf / Maria Uhl
Online erschienen: 21.04.2017 | DOI: https://doi.org/10.1515/bimo-2017-0001


Perfluoroalkylated substances (PFASs) are a class of synthetic chemicals used in a wide range of processes and products due to their unique physicalchemical properties. Through intake of PFASs via food or several consumer products, humans can be exposed. Long-chain PFASs have been associated with adverse effects in laboratory animals, and there is also evidence for adverse health effects in humans. Although investigations of human exposure are mainly conducted in blood samples, some studies have shown that especially short-chain PFASs can be detected in human urine. In the present study, a sensitive analytical method was adapted for the measurement of 12 PFASs in human urine samples by HPLC-MS/MS. For verifying this method, concentrations in 11 male and female participants aged 25-46 years were analysed. In the study population, ranges of urinary PFASs concentrations were n.d.- 8.5 ng/l for perfluoropentanoic acid, <LOQ-3.0 ng/l for perfluorohexanoic acid, n.d.-1.8 ng/l for perfluorohexane sulphonate, n.d.-0.99 ng/l for perfluoroheptanoic acid, 0.79-5.1 ng/l for perfluorooctanoic acid, <LOQ-4.9 ng/l for perfluorooctane suphonate, and <LOQ-0.57 ng/l for perfluorononanoic acid. For the other investigated PFASs, no urinary exposure could be identified in any of the samples. The present study shows that several shortchain PFASs are detectable in human urine.

Keywords : human biomonitoring; urinary PFAS; LC-MS/MS


  • [1] Haug L.S., Becher G., Biomarkers of Exposure: Perfluoroalkyl Compounds. In: Knudsen, L.E., Merlo, D.F. (Ed.). Biomarkers and Human Biomonitoring Volume 1: Ongoing Programs and Exposure, Issues in Toxicology No. 9, The Royal Society of Chemistry, Cambridge, UK, 2012.Google Scholar

  • [2] Perez F., Llorca M., Farré M., Barceó D., Automated analysis of perfluorinated compounds in human hair and urine samples by turbulent flow chromatography coupled to tandem mass spectrometry, Anal. Bioanal. Chem., 2012, 402, 2369-2378.Web of ScienceGoogle Scholar

  • [3] Buck R.C., Franklin J., Berger U., Conder J.M., Cousins I.T., de Voogt P., Jensen A.A., Kannan K., Mabury S.A., van Leeuwen S.P.J., Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins, Integr. Environ. Assess. Manag., 2011, 7, 513-541.Google Scholar

  • [4] Organisation for Economic Co-operation and Development, OECD portal on perfluorinated chemicals, 2017, http://www.oecd.org/ehs/pfc/Google Scholar

  • [5] European Food Safety Authority, Perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA) and their salts, Scientific Opinion of the Panel on Contaminants in the Food chain, The EFSA Journal 2008, 653, 1-131.Google Scholar

  • [6] European Union, Directive 2006/122/EC of the European Parliament and of the Council of 12 December 2006 amending for the 30th time Council Directive 76/769/EEC on the approximation of the laws, regulations and administrative provisions of the Member States relating to restrictions on the marketing and use of certain dangerous substances and preparations (perfluorooctane sulfonates), Official Journal of the European Union, L-372/32, 2006.Google Scholar

  • [7] United Nations Environment Programme, Decision SC-4/17: Listing of perfluorooctane sulfonic acid, its salts and perfluorooctane sulfonyl fluoride 2009, http://chm.pops.int/DNNADMIN/HiddenModulesforMandeepsPublications/OPsChemicalsMandeepshiddenmodule/tabid/754/Default.aspxGoogle Scholar

  • [8] United Nations Environment Programme, UNEP/POPS/POPRC. 12/11: Report of the Persistent Organic Pollutants Review Committee on the work of its twelfth meeting, 19-23 September 2016, Rome, Italy, 2016.Google Scholar

  • [9] European Chemicals Agency, Background document to the opinion on the Annex XV dossier proposing restrictions on perfluorooctanoic acid (PFOA), PFOA salts and PFOA-related substances, European Chemicals Agency, Helsinki, Finland, 2015.Google Scholar

  • [10] European Chemicals Agency, PACT - RMOA and hazard assessment activities, European Chemicals Agency, Helsinki, Finland, 2016, https://echa.europa.eu/addressing-chemicalsof-concern/substances-of-potential-concern/pactGoogle Scholar

  • [11] D’Hollander W., de Voogt P., De Coen W., Bervoets L., Perfluorinated substances in human food and other sources of human exposure, Rev. Environ. Contam. Toxicol., 2010, 208, 179-215.Google Scholar

  • [12] Stahl T., Mattern D., Brunn H., Toxicology of perfluorinated compounds, Environ. Sci., 2011, 23, 1-52.Google Scholar

  • [13] Lau C., Anitole K., Hodes C., Lai D., Pfahles-Hutchens A., Seed J., Perfluoroalkyl acids: a review of monitoring and toxicological findings, Toxicol. Sci., 2007, 99, 366-394.Google Scholar

  • [14] Danish Environmental Protection Agency, Survey of PFOS, PFOA and other perfluoroalkyl and polyfluoroalkyl substances, Danish Ministry of the Environment, Copenhagen, Denmark, 2013.Google Scholar

  • [15] Han X., Snow T.A., Jepson G.W., Binding of perfluorooctanoic acid to rat and human plasma proteins, Chem. Res. Toxicol., 2003, 16, 775-781.CrossrefGoogle Scholar

  • [16] Olsen G.W., Burris J.M., Ehresman D.J., Froehlich J.W., Seacat A.M., Butenhoff J.L., Zobel L.R., Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers, Environ. Health Perspect., 2007, 115, 1298-1305.Web of ScienceGoogle Scholar

  • [17] DeWitt J.C., Peden-Adams M.M., Keller J.M., Germolec D.R., Immunotoxicity of perfluorinated compounds: recent developments, Toxicol. Pathol., 2012, 40, 300-311.Web of ScienceGoogle Scholar

  • [18] European Chemicals Agency, Committee for Risk Assessment RAC Annex I - Background document to RAC opinion on perfluorooctanoic acid (PFOA), CLH Report proposal for harmonised classification and labelling, European Chemicals Agency, Helsinki, Finland, 2011, https://echa.europa.eu/documents/10162/dbb8ea98-2024-4687-a25b-785cf21535a3Google Scholar

  • [19] Cocker J., Mason H.J., Warren N.D., Cotton R.J., Creatinine adjustment of biological monitoring results, Occup. Med., 2011, 61, 349-353.Google Scholar

  • [20] Fromme H., Tittlemier S.A., Völkel W., Wilhelm M., Twardella D., Perfluorinated compounds - Exposure assessment for the general population in western countries, Int. J. Hyg. Environ. Health, 2009, 212, 239-270.Google Scholar

  • [21] Kennedy G.L. Jr., Butenhoff J.L., Olsen G.W., O’Connor J.C., Seacat A.M., Perkins R.G., Biegel L.B., Murphy S.R., Farrar D.G., The toxicology of perfluorooctanoate. Crit. Rev. Toxicol., 2004, 34, 351-384.CrossrefGoogle Scholar

  • [22] Lau C., Butenhoff J.L., Rogers J.M., The developmental toxicity of perfluoroalkyl acids and their derivates, Toxicol. Appl. Pharmacol., 2004, 198, 231-241.Google Scholar

  • [23] Fetcher T., Galloway T.S., Melzer D., Holcroft P., Cipelli R., Pilling L.C., Mondal D., Luster M., Harries L.W., Associations between PFOA, PFOS and changes in the expression of genes involved in cholesterol metabolism in humans, Environ. Int., 2013, 57-58, 2-10.Web of ScienceGoogle Scholar

  • [24] Saikat S., Kreis I., Davies B., Bridgman S., Kamanyire R., The impact of PFOS on health in the general population: a review, Environ. Sci. Process Impacts, 2013, 15, 329-335.Google Scholar

  • [25] Vieira V.M., Hoffman K., Shin H.-M., Weinberg J.M., Webster T.F., Fletcher T., Perfluorooctanoic acid exposure and cancer outcomes in a contaminated community: a geographic analysis, Environ. Health Perspect., 2013, 121, 318-323.Web of ScienceGoogle Scholar

  • [26] Butenhoff J.L., Olsen G.W., Pfahles-Hutchens A., The applicability of biomonitoring data for perfluorooctanesulfonate to the environmental public health continuum, Environ. Health Perspect., 2006, 114, 1776-1782.Google Scholar

  • [27] Kannan K., Corsolini S., Falandysz J., Fillmann G., Kumar K.S., Loganathan B.G., Mohd M.A., Olivero J., Van Wouwe N., Yang J.H., Aldous K.M., Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries, Environ. Sci. Technol., 2004, 38, 4489-4495.CrossrefGoogle Scholar

  • [28] Miralles-Marco A., Harrad S., Perfluorooctane sulfonate: A review of human exposure, biomonitoring and the environmental forensics utility of its chirality and isomer distribution, Environ. Int., 2015, 77, 148-159.Google Scholar

  • [29] Völkel W., Genzel-Boroviczény O., Demmelmair H., Gebauer C., Koletzko B., Twardella D., Raab U., Fromme H., Perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) in human breast milk: Results of a pilot study, Int. J. Hyg. Environ. Health, 2008, 211, 440-446.Google Scholar

  • [30] Beesoon S., Genuis S.J., Benskin J.P., Martin J.W., Exceptionally high serum concentrations of perfluorohexanesulfonate in a Canadian family are linked to home carpet treatment applications, Environ. Sci. Technol., 2012, 46, 12960-12967.Web of ScienceCrossrefGoogle Scholar

  • [31] Zhou Z., Shi Y., Vestergren R., Wang T., Liang Y., Cai Y., Highly elevated serum concentrations of perfluoroalkyl substances in fishery employees from Tangxun lake, China, Environ. Sci. Technol.,2014, 48, 3864-3874.CrossrefWeb of ScienceGoogle Scholar

  • [32] Harada K., Inoue K., Morikawa A., Yoshinaga T., Saito N., Koizumi A., Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion, Environ. Res., 2005, 99, 253-261.Google Scholar

  • [33] Genuis S.J., Birkholz D., Ralitsch M., Thibault N., Human detoxification of perfluorinated compounds, Public Health, 2010, 124, 367-375.Web of ScienceGoogle Scholar

  • [34] Zhang Y., Beesoon S., Zhu L., Martin J.W., biomonitoring of perfluoroalkyl acids in human urine and estimated of biological half-life, Environ. Sci. Technol., 2013, 47, 10619-10627.Google Scholar

  • [35] Zhang T., Sun H., Qin X., Gan Z., Kannan K., PFOS and PFOA in paired urine and blood from general adults and pregnant women: assessment of urinary elimination, Environ. Sci. Pollut. Res., 2015, 22, 5572-5579.Google Scholar

  • [36] Kim D.-H., Lee M.-Y., Oh J.-E., Perfluorinated compounds in serum and urine samples from children aged 5-13 years in South Korea, Environ. Pollut., 2014, 192, 171-178.Web of ScienceGoogle Scholar

  • [37] Li J., Guo F., Wang Y., Zhang J., Zhong Y., Zhao Y., Wu Y., Can nail, hair and urine be used for biomonitoring of human exposure to perfluorooctane sulfonate and perfluorooctanoic acid? Environ. Int., 2013, 53, 47-52.Web of ScienceCrossrefGoogle Scholar


Erhalten: 16.02.2017

Angenommen: 24.03.2017

Online erschienen: 21.04.2017

Erschienen im Druck: 01.04.2017

Quellenangabe: Biomonitoring, Band 4, Heft 1, Seiten 1–10, ISSN (Online) 2300-4606, DOI: https://doi.org/10.1515/bimo-2017-0001.

Zitat exportieren

© 2017. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License. BY-NC-ND 4.0

Zitierende Artikel

Hier finden Sie eine Übersicht über alle Crossref-gelisteten Publikationen, in denen dieser Artikel zitiert wird. Um automatisch über neue Zitierungen dieses Artikels informiert zu werden, aktivieren Sie einfach oben auf dieser Seite den „E-Mail-Alert: Neu zitiert“.

Na Wu, Dongmei Cai, Mengjie Guo, Mei Li, and Xiang Li
Science of The Total Environment, 2019, Jahrgang 667, Seite 594

Kommentare (0)